KR20000064632A - 에포니디핀염산염제제의제조방법 - Google Patents
에포니디핀염산염제제의제조방법 Download PDFInfo
- Publication number
- KR20000064632A KR20000064632A KR1019980707339A KR19980707339A KR20000064632A KR 20000064632 A KR20000064632 A KR 20000064632A KR 1019980707339 A KR1019980707339 A KR 1019980707339A KR 19980707339 A KR19980707339 A KR 19980707339A KR 20000064632 A KR20000064632 A KR 20000064632A
- Authority
- KR
- South Korea
- Prior art keywords
- hydrochloride
- treatment
- water
- mixture
- eponidipine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (6)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP96-088868 | 1996-03-18 | ||
| JP8886896 | 1996-03-18 | ||
| JP8886996 | 1996-03-18 | ||
| JP96-88869 | 1996-03-18 | ||
| PCT/JP1997/000842 WO1997034610A1 (en) | 1996-03-18 | 1997-03-17 | Process for producing efonidipine hydrochloride preparations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20000064632A true KR20000064632A (ko) | 2000-11-06 |
| KR100457273B1 KR100457273B1 (ko) | 2005-04-08 |
Family
ID=26430207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR10-1998-0707339A Expired - Fee Related KR100457273B1 (ko) | 1996-03-18 | 1997-03-17 | 에포니디핀염산염제제의제조방법 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6171599B1 (ko) |
| EP (1) | EP0893999B8 (ko) |
| KR (1) | KR100457273B1 (ko) |
| AT (1) | ATE223722T1 (ko) |
| AU (1) | AU1941897A (ko) |
| CA (1) | CA2248582C (ko) |
| DE (1) | DE69715395T2 (ko) |
| ES (1) | ES2184063T3 (ko) |
| PT (1) | PT893999E (ko) |
| TW (1) | TW487574B (ko) |
| WO (1) | WO1997034610A1 (ko) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0901786B1 (en) | 1997-08-11 | 2007-06-13 | Pfizer Products Inc. | Solid pharmaceutical dispersions with enhanced bioavailability |
| ZA200502495B (en) * | 2002-02-28 | 2005-09-20 | Japan Tobacco Inc | Ester compound and medicinal use thereof. |
| JP4832897B2 (ja) * | 2003-08-29 | 2011-12-07 | 日本たばこ産業株式会社 | エステル誘導体及びその医薬用途 |
| US20060030623A1 (en) * | 2004-07-16 | 2006-02-09 | Noboru Furukawa | Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis |
| WO2006038661A1 (ja) * | 2004-10-06 | 2006-04-13 | Eisai R & D Management Co., Ltd. | 医薬組成物及びその製造方法、並びに医薬組成物におけるジヒドロピリジン系化合物の安定化方法 |
| US8101774B2 (en) * | 2004-10-18 | 2012-01-24 | Japan Tobacco Inc. | Ester derivatives and medicinal use thereof |
| AU2005297923B2 (en) * | 2004-10-25 | 2010-12-23 | Japan Tobacco Inc. | Solid medicinal preparation improved in solubility and stability and process for producing the same |
| JP5103173B2 (ja) * | 2005-04-28 | 2012-12-19 | エルメッド エーザイ株式会社 | ジヒドロピリジン系化合物の分解を防止する方法 |
| JPWO2007108463A1 (ja) | 2006-03-23 | 2009-08-06 | 塩野義製薬株式会社 | 溶解性が改善された固形製剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1016063B (zh) * | 1986-01-22 | 1992-04-01 | 日产化学工业株式会社 | 二氢吡啶-5-膦酸环亚丙基酯的制备 |
| JP2528706B2 (ja) * | 1988-05-30 | 1996-08-28 | ゼリア新薬工業株式会社 | ジヒドロピリジン化合物の製剤組成物 |
-
1997
- 1997-03-17 DE DE69715395T patent/DE69715395T2/de not_active Expired - Fee Related
- 1997-03-17 CA CA002248582A patent/CA2248582C/en not_active Expired - Fee Related
- 1997-03-17 EP EP97907336A patent/EP0893999B8/en not_active Expired - Lifetime
- 1997-03-17 ES ES97907336T patent/ES2184063T3/es not_active Expired - Lifetime
- 1997-03-17 PT PT97907336T patent/PT893999E/pt unknown
- 1997-03-17 AT AT97907336T patent/ATE223722T1/de not_active IP Right Cessation
- 1997-03-17 US US09/142,208 patent/US6171599B1/en not_active Expired - Fee Related
- 1997-03-17 TW TW086103291A patent/TW487574B/zh not_active IP Right Cessation
- 1997-03-17 KR KR10-1998-0707339A patent/KR100457273B1/ko not_active Expired - Fee Related
- 1997-03-17 AU AU19418/97A patent/AU1941897A/en not_active Abandoned
- 1997-03-17 WO PCT/JP1997/000842 patent/WO1997034610A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2184063T3 (es) | 2003-04-01 |
| WO1997034610A1 (en) | 1997-09-25 |
| EP0893999B8 (en) | 2003-01-02 |
| KR100457273B1 (ko) | 2005-04-08 |
| ATE223722T1 (de) | 2002-09-15 |
| TW487574B (en) | 2002-05-21 |
| EP0893999A1 (en) | 1999-02-03 |
| US6171599B1 (en) | 2001-01-09 |
| PT893999E (pt) | 2002-12-31 |
| CA2248582C (en) | 2005-06-14 |
| EP0893999B1 (en) | 2002-09-11 |
| AU1941897A (en) | 1997-10-10 |
| DE69715395D1 (de) | 2002-10-17 |
| DE69715395T2 (de) | 2003-05-15 |
| CA2248582A1 (en) | 1997-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100498813B1 (ko) | 물에난용성인약물의비결정질화방법 | |
| KR100767349B1 (ko) | 페노피브레이트를 함유하는 경구용 약제 조성물 및 그의제조방법 | |
| KR100457273B1 (ko) | 에포니디핀염산염제제의제조방법 | |
| KR20110110097A (ko) | 수난용성 성분을 위한 메조포러스 물질 부형제 | |
| US6020384A (en) | Process for the manufacture of flavanolignan preparation with improved release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals | |
| EP2949322B1 (en) | Formulation for oral administration comprising melatonin in stable form and method of production thereof | |
| JP4074966B2 (ja) | 塩酸エホニジピン製剤の製造法 | |
| HU908395D0 (en) | Process for the production of medical preparation powder used for the preparation of tablets | |
| CN100528875C (zh) | 无结晶型态的印地普隆及其制备方法 | |
| US8062664B2 (en) | Process for preparing formulations of lipid-regulating drugs | |
| WO2002003957A2 (en) | Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same | |
| HK1225632A1 (zh) | 雷诺嗪和决奈达隆的药物组合物 | |
| KR20250116184A (ko) | 결절성 경화증 복합증의 치료 방법 | |
| EP1455838B1 (en) | Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment | |
| WO1999047175A1 (en) | Pharmaceutical compositions containing melatonin inclusion complexes | |
| RU2167649C2 (ru) | Способ получения твердой дисперсии умеренно водорастворимого лекарственного вещества (варианты) и фармацевтическая композиция | |
| EP0773783B1 (en) | Preparation of fusidic acid tablets | |
| KR20080011278A (ko) | 발로피 시타빈(val-mcyd)의 고형 경구 투여 형태 및그의 제조 방법 | |
| JPS61200942A (ja) | ビタミンK↓2−ジメチル−β−シクロデキストリン包接化合物 | |
| Chakravarty et al. | Importance of Drying in Small Molecule Drug Product Development | |
| WO2003007915A2 (en) | Compositions for treatment of head and neck cancers, and methods of making and using the same | |
| RU2289422C2 (ru) | Фармацевтическая композиция на основе ноопепта | |
| RU2275910C2 (ru) | Способ изготовления таблеток покрытых оболочкой, обладающих церебропротекторным, антиоксидантным и ноотропным действием | |
| JP2024138436A (ja) | 1-{2-[(3s,4r)-1-{[(3r,4r)-1-シクロペンチル-3-フルオロ-4-(4-メトキシフェニル)ピロリジン-3-イル]カルボニル}-4-(メトキシメチル)ピロリジン-3-イル]-5-(トリフルオロメチル)フェニル}ピペリジン-4-カルボン酸もしくはその医薬的に許容し得る塩又は共結晶を含有する医薬組成物 | |
| JP2009508932A (ja) | 非晶質アトルバスタチンのアニーリングプロセス |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| AMND | Amendment | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| AMND | Amendment | ||
| J201 | Request for trial against refusal decision | ||
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PJ0201 | Trial against decision of rejection |
St.27 status event code: A-3-3-V10-V11-apl-PJ0201 |
|
| B90T | Transfer of trial file for re-examination | ||
| PB0901 | Examination by re-examination before a trial |
St.27 status event code: A-6-3-E10-E12-rex-PB0901 |
|
| PB0901 | Examination by re-examination before a trial |
St.27 status event code: A-6-3-E10-E12-rex-PB0901 |
|
| B701 | Decision to grant | ||
| PB0701 | Decision of registration after re-examination before a trial |
St.27 status event code: A-3-4-F10-F13-rex-PB0701 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-3-3-R10-R18-oth-X000 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 4 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-5-5-R10-R17-oth-X000 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 5 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20101027 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
St.27 status event code: A-4-4-U10-U11-oth-PR1001 Fee payment year number: 7 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20111106 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20111106 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |